276 related articles for article (PubMed ID: 16981214)
1. Contact allergy to topical drugs: prevalence in a clinical setting and estimation of frequency at the population level.
de Pádua CA; Uter W; Schnuch A
Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):377-84. PubMed ID: 16981214
[TBL] [Abstract][Full Text] [Related]
2. Allergic contact dermatitis to topical drugs--epidemiological risk assessment.
de Pádua CA; Schnuch A; Nink K; Pfahlberg A; Uter W
Pharmacoepidemiol Drug Saf; 2008 Aug; 17(8):813-21. PubMed ID: 18383004
[TBL] [Abstract][Full Text] [Related]
3. Contact allergy to topical corticosteroids--results from the IVDK and epidemiological risk assessment.
Uter W; de Pádua CM; Pfahlberg A; Nink K; Schnuch A; Lessmann H
J Dtsch Dermatol Ges; 2009 Jan; 7(1):34-41, 34-42. PubMed ID: 18761609
[TBL] [Abstract][Full Text] [Related]
4. Contact allergy to neomycin sulfate: results of a multifactorial analysis.
Menezes de Pádua CA; Schnuch A; Lessmann H; Geier J; Pfahlberg A; Uter W
Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):725-33. PubMed ID: 15880442
[TBL] [Abstract][Full Text] [Related]
5. Acceptable risk of contact allergy in the general population assessed by CE-DUR--a method to detect and categorize contact allergy epidemics based on patient data.
Thyssen JP; Menné T; Schnuch A; Uter W; White I; White JM; Johansen JD
Regul Toxicol Pharmacol; 2009 Jul; 54(2):183-7. PubMed ID: 19383524
[TBL] [Abstract][Full Text] [Related]
6. [A common and insidious side-effect: allergic contact dermatitis caused by bufexamac used in the treatment of dermatitis. Results from the Information Network of Departments of Dermatology (IDVK)].
Schnuch A; Gefeller O; Uter W
Dtsch Med Wochenschr; 2005 Dec; 130(50):2881-6. PubMed ID: 16342011
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of contact allergy: an estimation of morbidity employing the clinical epidemiology and drug-utilization research (CE-DUR) approach.
Schnuch A; Uter W; Geier J; Gefeller O;
Contact Dermatitis; 2002 Jul; 47(1):32-9. PubMed ID: 12225411
[TBL] [Abstract][Full Text] [Related]
8. [Anogenital dermatoses--allergic and irritative causative factors. Analysis of IVDK data and review of the literature].
Kügler K; Brinkmeier T; Frosch PJ; Uter W
J Dtsch Dermatol Ges; 2005 Dec; 3(12):979-86. PubMed ID: 16405714
[TBL] [Abstract][Full Text] [Related]
9. Frequency of contact allergy in German children and adolescents patch tested between 1995 and 2002: results from the Information Network of Departments of Dermatology and the German Contact Dermatitis Research Group.
Heine G; Schnuch A; Uter W; Worm M
Contact Dermatitis; 2004 Sep; 51(3):111-7. PubMed ID: 15479199
[TBL] [Abstract][Full Text] [Related]
10. para-Phenylenediamine: the profile of an important allergen. Results of the IVDK.
Schnuch A; Lessmann H; Frosch PJ; Uter W
Br J Dermatol; 2008 Aug; 159(2):379-86. PubMed ID: 18510664
[TBL] [Abstract][Full Text] [Related]
11. [Contact allergy to topical ophthalmological drugs - epidemiological risk assessment].
Uter W; Menezes de Pádua C; Pfahlberg A; Nink K; Schnuch A; Behrens-Baumann W
Klin Monbl Augenheilkd; 2009 Jan; 226(1):48-53. PubMed ID: 19173163
[TBL] [Abstract][Full Text] [Related]
12. [Contact allergy to local steroids. Contact allergy to corticosteroids among consecutively tested patients with eczema].
Vestergaard L; Andersen KE
Ugeskr Laeger; 1997 Sep; 159(38):5662-6. PubMed ID: 9340873
[TBL] [Abstract][Full Text] [Related]
13. Relationship of patch test positivity in a general versus an eczema population.
Mirshahpanah P; Maibach HI
Contact Dermatitis; 2007 Mar; 56(3):125-30. PubMed ID: 17295685
[TBL] [Abstract][Full Text] [Related]
14. Surveillance of contact allergies: methods and results of the Information Network of Departments of Dermatology (IVDK).
Schnuch A; Geier J; Lessmann H; Arnold R; Uter W
Allergy; 2012 Jul; 67(7):847-57. PubMed ID: 22563651
[TBL] [Abstract][Full Text] [Related]
15. Is incident sensitization to p-phenylenediamine related to particular exposure patterns? Results of a questionnaire study.
Uter W; Hillen U; Geier J; ;
Contact Dermatitis; 2007 May; 56(5):266-70. PubMed ID: 17441848
[TBL] [Abstract][Full Text] [Related]
16. Rosacea and contact allergy to cosmetics and topical medicaments--retrospective analysis of multicentre surveillance data 1995-2002.
Jappe U; Schnuch A; Uter W
Contact Dermatitis; 2005 Feb; 52(2):96-101. PubMed ID: 15725288
[TBL] [Abstract][Full Text] [Related]
17. 10-year prevalence of contact allergy in the general population in Denmark estimated through the CE-DUR method.
Thyssen JP; Uter W; Schnuch A; Linneberg A; Johansen JD
Contact Dermatitis; 2007 Oct; 57(4):265-72. PubMed ID: 17868221
[TBL] [Abstract][Full Text] [Related]
18. Contact dermatitis to topical medicaments: a retrospective chart review from the Ottawa Hospital Patch Test Clinic.
Spring S; Pratt M; Chaplin A
Dermatitis; 2012; 23(5):210-3. PubMed ID: 23010827
[TBL] [Abstract][Full Text] [Related]
19. Allergic contact dermatitis due to beta-blockers in eye drops: a retrospective analysis of multicentre surveillance data 1993-2004.
Jappe U; Uter W; Menezes de Pádua CA; Herbst RA; Schnuch A
Acta Derm Venereol; 2006; 86(6):509-14. PubMed ID: 17106597
[TBL] [Abstract][Full Text] [Related]
20. Unusual patterns in contact dermatitis: medicaments.
Davis MD
Dermatol Clin; 2009 Jul; 27(3):289-97, vi. PubMed ID: 19580923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
